tfap2c  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc tfap2c
    (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for <t>TFAP2C</t> (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .
    Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tfap2c/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tfap2c - by Bioz Stars, 2023-03
    93/100 stars

    Images

    1) Product Images from "Coordination Between Embryo Growth and Trophoblast Migration Upon Implantation Delineates Mouse Embryogenesis"

    Article Title: Coordination Between Embryo Growth and Trophoblast Migration Upon Implantation Delineates Mouse Embryogenesis

    Journal: bioRxiv

    doi: 10.1101/2022.06.13.495767

    (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .
    Figure Legend Snippet: (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .

    Techniques Used: Immunofluorescence, Staining, In Utero, Embryo Culture, In Vitro, MANN-WHITNEY, Immunostaining

    tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc tfap2c
    Primers used in the study, along with the PubMed ID (PMID) of the original paper they were obtained from.
    Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tfap2c/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tfap2c - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Arid4b physically interacts with Tfap2c in mouse embryonic stem cells"

    Article Title: Arid4b physically interacts with Tfap2c in mouse embryonic stem cells

    Journal: Turkish Journal of Biology

    doi: 10.3906/biy-2010-67

    Primers used in the study, along with the PubMed ID (PMID) of the original paper they were obtained from.
    Figure Legend Snippet: Primers used in the study, along with the PubMed ID (PMID) of the original paper they were obtained from.

    Techniques Used: Sequencing

    Antibodies used in the study.
    Figure Legend Snippet: Antibodies used in the study.

    Techniques Used:

    tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc tfap2c
    Complete listing of genes within each network.
    Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tfap2c/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tfap2c - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Intertwining Threshold Settings, Biological Data and Database Knowledge to Optimize the Selection of Differentially Expressed Genes from Microarray"

    Article Title: Intertwining Threshold Settings, Biological Data and Database Knowledge to Optimize the Selection of Differentially Expressed Genes from Microarray

    Journal: PLoS ONE

    doi: 10.1371/journal.pone.0013518

    Complete listing of genes within each network.
    Figure Legend Snippet: Complete listing of genes within each network.

    Techniques Used: Cell Function Assay

    antibodies anti tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc antibodies anti tfap2c
    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for <t>TFAP2C,</t> NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.
    Antibodies Anti Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies anti tfap2c/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    antibodies anti tfap2c - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "In vitro germ cell induction from fertile and infertile monozygotic twin research participants"

    Article Title: In vitro germ cell induction from fertile and infertile monozygotic twin research participants

    Journal: Cell Reports Medicine

    doi: 10.1016/j.xcrm.2022.100782

    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for TFAP2C, NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.
    Figure Legend Snippet: Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for TFAP2C, NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.

    Techniques Used:


    Figure Legend Snippet:

    Techniques Used:

    anti tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anti tfap2c
    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for <t>TFAP2C,</t> NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.
    Anti Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti tfap2c/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti tfap2c - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "In vitro germ cell induction from fertile and infertile monozygotic twin research participants"

    Article Title: In vitro germ cell induction from fertile and infertile monozygotic twin research participants

    Journal: Cell Reports Medicine

    doi: 10.1016/j.xcrm.2022.100782

    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for TFAP2C, NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.
    Figure Legend Snippet: Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for TFAP2C, NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.

    Techniques Used:


    Figure Legend Snippet:

    Techniques Used:

    tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc tfap2c
    (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for <t>TFAP2C</t> (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .
    Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tfap2c/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tfap2c - by Bioz Stars, 2023-03
    93/100 stars

    Images

    1) Product Images from "Coordination Between Embryo Growth and Trophoblast Migration Upon Implantation Delineates Mouse Embryogenesis"

    Article Title: Coordination Between Embryo Growth and Trophoblast Migration Upon Implantation Delineates Mouse Embryogenesis

    Journal: bioRxiv

    doi: 10.1101/2022.06.13.495767

    (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .
    Figure Legend Snippet: (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .

    Techniques Used: Immunofluorescence, Staining, In Utero, Embryo Culture, In Vitro, MANN-WHITNEY, Immunostaining

    tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc tfap2c
    (a) Expression of trophoblast markers as measured by RT-PCR in pdTSCs that were maintained for prolonged time (10-15 Passages) in TSC-m medium, or in primed hPSCs, compared to native TSC lines bTS5 and CT30. (n=3) (b) Immunostaining of trophoblast markers CK7, GATA3 and <t>TFAP2C</t> in cells that were maintained for prolonged time (15 Passages) in TSC-m medium. (c) FACS analysis of H1, WIBR3 and JHiPS pdTSCs, measuring anti-ITGA6 or IgG (negative control), after 15 passages in TSC-m medium. (d) Methylation levels of ELF5 promoter, as measured in primed hPSC (left) and in pdTSC (right). (e) Karyotype analysis for H1, JHiPS and WIBR3 pdTSCs.
    Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tfap2c/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tfap2c - by Bioz Stars, 2023-03
    93/100 stars

    Images

    1) Product Images from "Human primed and naïve PSCs are both competent in differentiating into bona fide trophoblast stem cells"

    Article Title: Human primed and naïve PSCs are both competent in differentiating into bona fide trophoblast stem cells

    Journal: bioRxiv

    doi: 10.1101/2022.05.20.492766

    (a) Expression of trophoblast markers as measured by RT-PCR in pdTSCs that were maintained for prolonged time (10-15 Passages) in TSC-m medium, or in primed hPSCs, compared to native TSC lines bTS5 and CT30. (n=3) (b) Immunostaining of trophoblast markers CK7, GATA3 and TFAP2C in cells that were maintained for prolonged time (15 Passages) in TSC-m medium. (c) FACS analysis of H1, WIBR3 and JHiPS pdTSCs, measuring anti-ITGA6 or IgG (negative control), after 15 passages in TSC-m medium. (d) Methylation levels of ELF5 promoter, as measured in primed hPSC (left) and in pdTSC (right). (e) Karyotype analysis for H1, JHiPS and WIBR3 pdTSCs.
    Figure Legend Snippet: (a) Expression of trophoblast markers as measured by RT-PCR in pdTSCs that were maintained for prolonged time (10-15 Passages) in TSC-m medium, or in primed hPSCs, compared to native TSC lines bTS5 and CT30. (n=3) (b) Immunostaining of trophoblast markers CK7, GATA3 and TFAP2C in cells that were maintained for prolonged time (15 Passages) in TSC-m medium. (c) FACS analysis of H1, WIBR3 and JHiPS pdTSCs, measuring anti-ITGA6 or IgG (negative control), after 15 passages in TSC-m medium. (d) Methylation levels of ELF5 promoter, as measured in primed hPSC (left) and in pdTSC (right). (e) Karyotype analysis for H1, JHiPS and WIBR3 pdTSCs.

    Techniques Used: Expressing, Reverse Transcription Polymerase Chain Reaction, Immunostaining, Negative Control, Methylation

    rabbit anti tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Cell Signaling Technology Inc rabbit anti tfap2c
    Rabbit Anti Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti tfap2c/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti tfap2c - by Bioz Stars, 2023-03
    93/100 stars

    Images

    anti tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc anti tfap2c
    KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, <t>TFAP2C,</t> NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.
    Anti Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti tfap2c/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti tfap2c - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Principles of signaling pathway modulation for enhancing human naive pluripotency induction"

    Article Title: Principles of signaling pathway modulation for enhancing human naive pluripotency induction

    Journal: Cell Stem Cell

    doi: 10.1016/j.stem.2021.04.001

    KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, TFAP2C, NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.
    Figure Legend Snippet: KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, TFAP2C, NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.

    Techniques Used: Binding Assay, ChIP-sequencing


    Figure Legend Snippet:

    Techniques Used: Recombinant, Protease Inhibitor, Methylation, Purification, DNA Methylation Assay, Transfection, Construct, Software

    tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Cell Signaling Technology Inc tfap2c
    KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, <t>TFAP2C,</t> NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.
    Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tfap2c/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tfap2c - by Bioz Stars, 2023-03
    86/100 stars

    Images

    1) Product Images from "Principles of signaling pathway modulation for enhancing human naive pluripotency induction"

    Article Title: Principles of signaling pathway modulation for enhancing human naive pluripotency induction

    Journal: Cell Stem Cell

    doi: 10.1016/j.stem.2021.04.001

    KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, TFAP2C, NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.
    Figure Legend Snippet: KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, TFAP2C, NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.

    Techniques Used: Binding Assay, ChIP-sequencing


    Figure Legend Snippet:

    Techniques Used: Recombinant, Protease Inhibitor, Methylation, Purification, DNA Methylation Assay, Transfection, Construct, Software

    rabbit anti tfap2c  (Cell Signaling Technology Inc)


    Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
    Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Cell Signaling Technology Inc rabbit anti tfap2c
    KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, <t>TFAP2C,</t> NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.
    Rabbit Anti Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti tfap2c/product/Cell Signaling Technology Inc
    Average 96 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti tfap2c - by Bioz Stars, 2023-03
    96/100 stars

    Images

    1) Product Images from "Principles of signaling pathway modulation for enhancing human naive pluripotency induction"

    Article Title: Principles of signaling pathway modulation for enhancing human naive pluripotency induction

    Journal: Cell Stem Cell

    doi: 10.1016/j.stem.2021.04.001

    KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, TFAP2C, NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.
    Figure Legend Snippet: KLF17 is a key promoter of human naive pluripotency (A) Motif enrichment in HENSM-specific and primed-specific accessible chromatin regions (n = 20,642 and b = 36,927, respectively). Motif families are indicated at the right. Shades represent enrichment fold change. (B) Primed WT and KO hESCs for KLF4 and/or KLF17 were reverted in HENSM and HENSM-ACT conditions, imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (C) WT and KO mESCs for Klf17 were expanded in 2iL, phase imaged, and assayed for OCT4-GFP by FACS analysis (values indicated per frame). (D) Genomic annotation of binding sites of KLF17, KLF4, TFAP2C, NANOG, OCT4, and SOX2 measured in HENSM naive or primed conditions, showing the preference of KLF17 to bind promoters, compared to all TFs that prefer to bind enhancers (distal intergenic + introns annotations). (E) KLF17 binding pattern (average Z score + STD) in naive-specific regions (n = 20,642, blue), primed-specific regions (n = 36,927, red), or all promoters (n = 43,463, gray). (F) Overlap between target genes of the indicated TFs, showing highest overlap between Sox2 and Oct4 target genes (p ~0) and a relative lower overlap with KLF17 and KLF4 targets (p < 10 −21 ). Scaled p value is presented . (G) ChIP-seq profile of KLF17, OCT4, and SOX2 in selected regions and different conditions in hPSCs. IGV range common to all tracks is indicated.

    Techniques Used: Binding Assay, ChIP-sequencing


    Figure Legend Snippet:

    Techniques Used: Recombinant, Protease Inhibitor, Methylation, Purification, DNA Methylation Assay, Transfection, Construct, Software

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93
    Cell Signaling Technology Inc tfap2c
    (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for <t>TFAP2C</t> (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .
    Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tfap2c/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    tfap2c - by Bioz Stars, 2023-03
    93/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc antibodies anti tfap2c
    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for <t>TFAP2C,</t> NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.
    Antibodies Anti Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies anti tfap2c/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    antibodies anti tfap2c - by Bioz Stars, 2023-03
    86/100 stars
      Buy from Supplier

    86
    Cell Signaling Technology Inc anti tfap2c
    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for <t>TFAP2C,</t> NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.
    Anti Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti tfap2c/product/Cell Signaling Technology Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti tfap2c - by Bioz Stars, 2023-03
    86/100 stars
      Buy from Supplier

    93
    Cell Signaling Technology Inc rabbit anti tfap2c
    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for <t>TFAP2C,</t> NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.
    Rabbit Anti Tfap2c, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti tfap2c/product/Cell Signaling Technology Inc
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    rabbit anti tfap2c - by Bioz Stars, 2023-03
    93/100 stars
      Buy from Supplier

    Image Search Results


    (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .

    Journal: bioRxiv

    Article Title: Coordination Between Embryo Growth and Trophoblast Migration Upon Implantation Delineates Mouse Embryogenesis

    doi: 10.1101/2022.06.13.495767

    Figure Lengend Snippet: (A) Left, representative immunofluorescence image of the E4.75 uterus cross-section, simultaneously stained for Fibronectin (FN1, white), GATA4 (green), and nuclei (DNA, blue). Right, 4x zoom into the interface between trophectoderm (TE), uterine epithelium (E), and stroma (S) (outlined). Red arrowheads mark uterine ECM. (B) Representative immunofluorescence image of the E5.25 uterus cross-section, simultaneously stained for pan-Laminin (panLAM, white), GATA4 (green), and nuclei (DNA, blue). Measurements of E5.25 in utero embryo dimension across n = 12. (C) Schematic illustration of peri-implantation embryo culture. Embryos are recovered at E3.5, treated by Tyrode’s solution to remove Zona pellucida (ZP), and embedded into the crypts on the day of recovery (D0). ICM, red; TE, blue; IVC1 and ICV2 stand for “In Vitro Culture” medium 1 and 2, respectively. Inset, schematic illustration of the hydrogel composition. 8-arm Poly(ethylene glycol) (PEG, gray) molecules, crosslinked via metalloprotease-cleavable peptides (Peptide, green), and functionalized with RGDSPG peptide (Arg-Gly-Asp-Ser-Pro-Gly, ‘RGD’, red). (D) Representative immunofluorescence images of the embryos developed in utero until E4.5 and E5.25, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (E) Representative immunofluorescence images of the 3E-uterus embryos from day 2 and 3, simultaneously stained for OCT3/4 (magenta), GATA4 (green), and nuclei (DAPI, blue). (F) Scatterplot showing numbers of epiblast (EPI) cells (x-axis) vs numbers of visceral endoderm (VE) cells (y-axis) that cover epiblast in the embryos developed in utero until E5.5 (E3.5 – E5.5) and the embryos developed by 3E-uterus until day 3 (D1 – 3). n = 5 (E3.5), n = 21 (E4.5), n = 28 (E4.75), n = 20 (E5.0), n = 20 (E5.25), n = 21 (E5.5), data from ; n = 20, two replicates pooled (D1), n = 13 of 28, three replicates pooled (D2), n = 12 of 26, three replicates pooled (D3). X/Y scale, log 10. Bottom right, the scheme of the quantified embryo region, EPI (magenta), VE (green). (G) From left to right, boxplots showing egg cylinder’s length, diameter, and the length-to-diameter ratio between embryos developed in utero until E5.25 and 3E-uterus embryos from day 3 (D3). n = 14 and 12, respectively. Data points, shown as black dots, correspond to individual embryos, midline marks the median, boxes indicate interquartile range. P-values were calculated using Student’s t-test and the Mann-Whitney U test. (H) Cell number-based correspondence between in utero and 3E-uterus embryo development. (I) Left, representative immunofluorescence image of the E4.75 uterus cross-section from the pregnant F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 2 (D2). Yellow arrowheads mark differentiated trophoblast cells. (J) Left, representative immunofluorescence image of the E5.25 uterus cross-section from the F1 female mated with the H2B-GFP male. Simultaneous immunostaining for TFAP2C (yellow), GFP (green), and nuclei (DNA, blue). Right, immunostaining of the 3E-uterus embryo from day 3 (D3). Scale bars, 50 μm, 12.5 μm (4x zoom). White asterisks mark epiblast of the implanted embryos. See also Materials and Methods, .

    Article Snippet: Primary antibodies against GATA4 biotinylated (R&D systems, AF2606), SOX2 (Cell Signaling, 23064), TFAP2C (Cell Signaling, #2320), CDX2 (Biogenex Laboratories, MU392AUC), PARD6B (Santa Cruz Biotechnology, sc-67393), pan-Laminin (Novus Biologicals, NB300-144SS), Collagen IV (Millipore, AB756P), Fibronectin (Proteintech, 15613-1-AP), ITGB1 (Millipore, MAB1997), GFP (chromotek, gb2AF488) were diluted at 1:200.

    Techniques: Immunofluorescence, Staining, In Utero, Embryo Culture, In Vitro, MANN-WHITNEY, Immunostaining

    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for TFAP2C, NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.

    Journal: Cell Reports Medicine

    Article Title: In vitro germ cell induction from fertile and infertile monozygotic twin research participants

    doi: 10.1016/j.xcrm.2022.100782

    Figure Lengend Snippet: Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for TFAP2C, NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.

    Article Snippet: The primary antibodies anti-TFAP2C (sc8977; 1:200, RRID: AB_2286995 ), anti-TFAP2C (sc12762; 1:200, RRID: AB_667770 ), anti-BLIMP1 (Cell Signaling C14A4; 1:100, RRID: AB_2169699 ), anti-SOX17 (GT15094; 1:100, RRID: AB_2195648 ), anti-BRACHYURY/T (Fisher Scientific AF2085; 1:200, RRID: AB_2200235 ), anti-NANOG (ab109250, 1:40, RRID: AB_10863442 ), anti-TFAP2A (sc-12726, 1:200, RRID: AB_667767 ) were incubated overnight at 4°C.

    Techniques:

    Journal: Cell Reports Medicine

    Article Title: In vitro germ cell induction from fertile and infertile monozygotic twin research participants

    doi: 10.1016/j.xcrm.2022.100782

    Figure Lengend Snippet:

    Article Snippet: The primary antibodies anti-TFAP2C (sc8977; 1:200, RRID: AB_2286995 ), anti-TFAP2C (sc12762; 1:200, RRID: AB_667770 ), anti-BLIMP1 (Cell Signaling C14A4; 1:100, RRID: AB_2169699 ), anti-SOX17 (GT15094; 1:100, RRID: AB_2195648 ), anti-BRACHYURY/T (Fisher Scientific AF2085; 1:200, RRID: AB_2200235 ), anti-NANOG (ab109250, 1:40, RRID: AB_10863442 ), anti-TFAP2A (sc-12726, 1:200, RRID: AB_667767 ) were incubated overnight at 4°C.

    Techniques:

    Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for TFAP2C, NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.

    Journal: Cell Reports Medicine

    Article Title: In vitro germ cell induction from fertile and infertile monozygotic twin research participants

    doi: 10.1016/j.xcrm.2022.100782

    Figure Lengend Snippet: Induction of hPGCLCs in an embryo model of the amniotic sac (A) Diagram of the embryo model. BMP4 was added 18 h after loading hiPSCs into the device. Thirty h after adding BMP4, amniotic sac-like embryo models develop, each containing an amniotic cavity, an amniotic ectoderm-like cell layer, pre-primitive streak epiblast (EPI)-like cells, and hPGCLCs (right). (B) The amniotic ectoderm-like cell layer is TFAP2A+ (n = 12 modeled embryos per participant were evaluated). Scale bar: 30 μm. (C) Representative images of hPGCLCs (triple positive for TFAP2C, NANOG, and SOX17) in the amniotic ectoderm-like cell layer (shown is MZT05-D). Arrows indicate hPGCLCs. (D) The number of specified hPGCLCs in the amniotic ectoderm-like cell layer was quantified from n = 8 embryo models from each participant’s hiPSCs (MZT01 versus MZT02, p = 0.58; MZT04 versus MZT06, p = 0.30). Scale bar: 10 μm. Data are represented as mean ± SEM. Figure created with BioRender.com . Statistical significance was calculated using t test.

    Article Snippet: The primary antibodies anti-TFAP2C (sc8977; 1:200, RRID: AB_2286995 ), anti-TFAP2C (sc12762; 1:200, RRID: AB_667770 ), anti-BLIMP1 (Cell Signaling C14A4; 1:100, RRID: AB_2169699 ), anti-SOX17 (GT15094; 1:100, RRID: AB_2195648 ), anti-BRACHYURY/T (Fisher Scientific AF2085; 1:200, RRID: AB_2200235 ), anti-NANOG (ab109250, 1:40, RRID: AB_10863442 ), anti-TFAP2A (sc-12726, 1:200, RRID: AB_667767 ) were incubated overnight at 4°C.

    Techniques:

    Journal: Cell Reports Medicine

    Article Title: In vitro germ cell induction from fertile and infertile monozygotic twin research participants

    doi: 10.1016/j.xcrm.2022.100782

    Figure Lengend Snippet:

    Article Snippet: The primary antibodies anti-TFAP2C (sc8977; 1:200, RRID: AB_2286995 ), anti-TFAP2C (sc12762; 1:200, RRID: AB_667770 ), anti-BLIMP1 (Cell Signaling C14A4; 1:100, RRID: AB_2169699 ), anti-SOX17 (GT15094; 1:100, RRID: AB_2195648 ), anti-BRACHYURY/T (Fisher Scientific AF2085; 1:200, RRID: AB_2200235 ), anti-NANOG (ab109250, 1:40, RRID: AB_10863442 ), anti-TFAP2A (sc-12726, 1:200, RRID: AB_667767 ) were incubated overnight at 4°C.

    Techniques: